Navigation Links
Ampio Responds to Recent Publications by Anonymous Short Sellers
Date:12/16/2011

and other collaboration opportunities to maximize Ampio's product development programs.  For more information about Ampio, please visit our website, www.ampiopharma.com.

Forward-Looking Statements

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Contact: -- Investor Relations --
Ampio Pharmaceuticals, Inc.-- 720-437-6500


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
2. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
3. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
4. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
5. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
6. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
7. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
8. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
9. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
10. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
11. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Oct. 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ...  What: , Isis Pharmaceuticals, Third Quarter 2014 Financial ... 7 at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... the Internet. Simply log onto our website listed above. ... event, a replay of the webcast will be available ...
(Date:10/30/2014)... /CNW/ - Atlantic Canadians will save an estimated $560-million ... Canada,s provinces and territories and the generic ... Canadian Generic Pharmaceutical Association (CGPA), said today. ... the Atlantic Summit on Healthcare and Drug Cost Sustainability ... hosted by the Public Policy Forum and sponsored by ...
(Date:10/30/2014)... , Oct. 30, 2014   NxStage® Kidney Care, ... NXTM ), is proud to host the grand opening ... center at 1600 W. 16 th Street on November ... operated by highly trained medical staff who are committed to ... quality of life benefits made possible through more flexible dialysis ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3Grand Opening of NxStage Kidney Care Oak Brook IL Center 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 3
... Dec. 12, 2010 Nektar Therapeutics (Nasdaq: ... a Phase 2 clinical study evaluating single-agent NKTR-102 ... 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium ... conjugate, is Nektar,s lead oncology candidate and is ...
... THE WOODLANDS, Texas, Dec. 10, 2010 Joyce ... Breast Cancer Research Committee, US Oncology Research , ... Cancer Center, presented her study findings today at the ... ), an international scientific symposium for interaction and exchange ...
Cached Medicine Technology:NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 2NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 3NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 4NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 5NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 6NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 7NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 8NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 9Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 2Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 3Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 4Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 5
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 The ... program was created by Alexander Lynch, whose father suffered from ... through a dramatic moment, caused by his father's disease. His ... crisis. That was the crucial moment when the author of ... help his dad. , The Memory Healer program is ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 With all ... one Midwest optometrist feels they may overlook one critical ... affect areas like concentration, school performance and even behavior. ... too brief to identify progressive vision problems, and to ... Mo., announces a new initiative: The Awesome Eyes Student ...
(Date:10/31/2014)... (HealthDay News) -- Obesity increases the risk of certain ... women, two new U.S. studies show. One study ... or obese increased the risk for estrogen receptor-negative and ... known this for a long time for white women, ... women," study author Esther John, a senior research scientist ...
(Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
(Date:10/31/2014)... 31, 2014 Florida Air Academy, ... girls in grades 6-12, is taking the lead ... injuries and concussions, becoming the first high school ... (Immediate Post-Concussion Assessment and Cognitive Testing) computerized assessment ... Player' lawsuit grabs the headlines, and the Centers ...
Breaking Medicine News(10 mins):Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... Kerr, MD,Director of the Bowen Center for the Study ... address the topic of autism in the,family., ASD ... widely,discussed and intensively researched clinical entities in medicine.,Passionate debate ... the,number of children diagnosed to be on the autistic ...
... Southern Home Medical,Equipment, Inc. (OTC: SHOM) announced today that ... in the second quarter of 2008,compared to the first ... Company, stated, "We have focused a significant portion of ... Encore Medical Staffing. We are,very excited to see that ...
... (Nasdaq: RURL ) issued another reminder today for ... Company,s common stock in relation,to its ongoing analysis of ... U.S. Internal Revenue Code ("Section 382")., In general, ... operating,losses and certain other tax benefits following a change ...
... Should Know Their Income History; Allsup Answers Common Benefits Questions ... ... who find themselves with a mental or physical disability face many ... accept that they no longer can work. While everything about a ...
... Gastroenterology care, selects MxSecure, Inc., the nation's leading provider of ... transcription provider for accurate and timely transcription reports. , ... ... - MxSecure, Inc , the nation's leading provider of ...
... Study is one of few trials to recruit large percentage of African ... ... Keeping a food diary can double,a person,s weight loss according to ... of the largest and longest,running weight loss maintenance trials ever conducted, will ...
Cached Medicine News:Health News:Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63% 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: